Volume 18, Issue 2, Pages (February 2016)

Slides:



Advertisements
Similar presentations
a GM DM1 DM3 DM5 DM7 b MHC MHC +DAPI GM DM4
Advertisements

Volume 7, Issue 4, Pages (October 2010)
Volume 20, Issue 6, Pages (December 2014)
Volume 8, Issue 5, Pages (May 2017)
DNMT3B Overexpression by Deregulation of FOXO3a-Mediated Transcription Repression and MDM2 Overexpression in Lung Cancer  Yi-Chieh Yang, MS, Yen-An Tang,
Pax7 Is Required for the Specification of Myogenic Satellite Cells
Volume 18, Issue 1, Pages (January 2016)
Chromatin Effector Pygo2 Mediates Wnt-Notch Crosstalk to Suppress Luminal/Alveolar Potential of Mammary Stem and Basal Cells  Bingnan Gu, Kazuhide Watanabe,
Michael W. Linhoff, Saurabh K. Garg, Gail Mandel  Cell 
Volume 11, Issue 2, Pages (August 2012)
Volume 9, Issue 1, Pages (July 2017)
Compacting Chromatin to Ensure Muscle Satellite Cell Quiescence
Volume 10, Issue 6, Pages (June 2018)
Volume 18, Issue 9, Pages (February 2017)
Volume 24, Issue 13, Pages e5 (September 2018)
Volume 21, Issue 11, Pages (December 2017)
Volume 22, Issue 2, Pages e7 (February 2018)
P63 Transcription Factor Regulates Nuclear Shape and Expression of Nuclear Envelope-Associated Genes in Epidermal Keratinocytes  Valentina Rapisarda,
Volume 18, Issue 10, Pages (March 2017)
Volume 122, Issue 2, Pages (July 2005)
SOX7 Is Required for Muscle Satellite Cell Development and Maintenance
Volume 13, Issue 5, Pages (November 2013)
Volume 14, Issue 8, Pages (March 2016)
Volume 36, Issue 2, Pages (January 2016)
Volume 10, Issue 2, Pages (February 2018)
Volume 10, Issue 5, Pages (May 2012)
Volume 16, Issue 2, Pages (July 2016)
Volume 7, Issue 9, Pages (September 2014)
Volume 44, Issue 3, Pages e7 (February 2018)
Volume 11, Issue 1, Pages (July 2012)
Volume 16, Issue 3, Pages (March 2015)
Volume 26, Issue 2, Pages (July 2013)
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 24, Issue 2, Pages (February 2016)
Volume 14, Issue 8, Pages (March 2016)
Volume 143, Issue 1, Pages (October 2010)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
Volume 27, Issue 8, Pages (April 2017)
Volume 9, Issue 3, Pages (September 2017)
Volume 7, Issue 1, Pages (January 2008)
Volume 4, Issue 6, Pages (June 2009)
An HMGA2-IGF2BP2 Axis Regulates Myoblast Proliferation and Myogenesis
Chromatin Effector Pygo2 Mediates Wnt-Notch Crosstalk to Suppress Luminal/Alveolar Potential of Mammary Stem and Basal Cells  Bingnan Gu, Kazuhide Watanabe,
Volume 16, Issue 5, Pages (August 2016)
Volume 10, Issue 4, Pages (April 2018)
Volume 22, Issue 1, Pages e3 (January 2018)
Codependent Activators Direct Myoblast-Specific MyoD Transcription
Devendra S. Mistry, Yifang Chen, George L. Sen  Cell Stem Cell 
Dimethylation of H3K4 by Set1 Recruits the Set3 Histone Deacetylase Complex to 5′ Transcribed Regions  TaeSoo Kim, Stephen Buratowski  Cell  Volume 137,
Shihuan Kuang, Kazuki Kuroda, Fabien Le Grand, Michael A. Rudnicki 
Volume 10, Issue 3, Pages (March 2012)
Volume 20, Issue 4, Pages (April 2011)
Conditional Loss of Pten in Myogenic Progenitors Leads to Postnatal Skeletal Muscle Hypertrophy but Age-Dependent Exhaustion of Satellite Cells  Feng.
Muscle Satellite Cells Are Primed for Myogenesis but Maintain Quiescence with Sequestration of Myf5 mRNA Targeted by microRNA-31 in mRNP Granules  Colin G.
Telomeric Noncoding RNA TERRA Is Induced by Telomere Shortening to Nucleate Telomerase Molecules at Short Telomeres  Emilio Cusanelli, Carmina Angelica Perez.
EVA1A/TMEM166 Regulates Embryonic Neurogenesis by Autophagy
Nur Hayati Jaafar Marican, Sara B. Cruz-Migoni, Anne-Gaëlle Borycki 
Swapna Kollu, Rana Abou-Khalil, Carl Shen, Andrew S. Brack 
Volume 27, Issue 5, Pages (September 2007)
PRMT7 Preserves Satellite Cell Regenerative Capacity
Short Telomeres in ESCs Lead to Unstable Differentiation
Volume 16, Issue 4, Pages (April 2009)
Volume 6, Issue 2, Pages (February 2010)
Volume 5, Issue 3, Pages (September 2009)
Volume 11, Issue 2, Pages (August 2018)
Volume 55, Issue 1, Pages (July 2014)
Volume 11, Issue 3, Pages (September 2012)
Volume 27, Issue 7, Pages e5 (May 2019)
Suchitra D. Gopinath, Ashley E. Webb, Anne Brunet, Thomas A. Rando 
Presentation transcript:

Volume 18, Issue 2, Pages 229-242 (February 2016) Regulation of Skeletal Muscle Stem Cell Quiescence by Suv4-20h1-Dependent Facultative Heterochromatin Formation  Verawan Boonsanay, Ting Zhang, Angelina Georgieva, Sawa Kostin, Hui Qi, Xuejun Yuan, Yonggang Zhou, Thomas Braun  Cell Stem Cell  Volume 18, Issue 2, Pages 229-242 (February 2016) DOI: 10.1016/j.stem.2015.11.002 Copyright © 2016 Elsevier Inc. Terms and Conditions

Cell Stem Cell 2016 18, 229-242DOI: (10.1016/j.stem.2015.11.002) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 MuSCs Maintain a Facultative Heterochromatic Configuration (A) Immunofluorescence staining of the chromatin modification H3K9me3, H3K27me3, H4K20me1, H4K20me2, and H4K20me3 in MuSCs (Pax7+) attached to freshly isolated myofibers from EDL muscles. Scale bar represents 20 μm. (B) Quantification of different epigenetic modifications and Pax7+ double-positive cells. (C) Western blot analysis of chromatin modifications in quiescent (Quiescent SC) and proliferating satellite cells (Proliferating SC) after 2 days in culture. Histone H3 is used as internal control. (D) RT-qPCR expression analysis of enzymes regulating H4K20 methylation in quiescent MuSCs and proliferating MuSCs. ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 (n = 3). (E) RT-qPCR expression analysis of enzymes regulating H3K27 methylation in quiescent and proliferating MuSCs. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 (n = 3). See also Figure S1. Cell Stem Cell 2016 18, 229-242DOI: (10.1016/j.stem.2015.11.002) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 Inactivation of Suv4-20h1 in MuSCs Reduces fHC Formation, Disrupts MuSC Quiescence, and Impairs Long-Term Muscle Regeneration (A) Representative EM images demonstrating reduction of condensed heterochromatin and increase of cytoplasm in MuSC of Suv4-20h1mKO mice. Scale bar represents 2 μm. Percentages of MuSC numbers with distinct heterochromatin contents (hetero) in WT and mutant muscles are shown on the right. ∗p < 0.05, ∗∗∗p < 0.001 (n = 3). (B and C) Immunofluorescence analysis of H4K20me2 (red) (B) and H3K27me3 (red) (C) in MuSCs (Pax7+, green) attached to freshly isolated myofibers of Suv4-20h1mKO mutant and WT mice. Scale bar represents 20 μm. Quantifications are shown on the right. ∗∗p < 0.01, ∗∗∗p < 0.001 (n = 6). (D) Immunofluorescence staining of activated (Pax7+/MyoD+) MuSCs of WT and Suv4-20h1mKO mutant mice. Scale bar represents 20 μm. Quantifications are shown on the right. ∗∗p < 0.01 (n = 6). (E) H&E staining of TA muscles from WT and Suv4-20h1mKO mice after three times CTX injection. Scale bar represents 20 μm. (F) Quantification of Pax7+ MuSCs in regenerated TA muscles of Suv4-20h1mKO and WT muscles after three rounds of regeneration (ten sections per mouse). ∗∗p < 0.01 (n = 6). See also Figures S2 and S3. Cell Stem Cell 2016 18, 229-242DOI: (10.1016/j.stem.2015.11.002) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 Inactivation of Suv4-20h1 in Adult MuSCs Causes Loss of fHC, Stem Cell Quiescence, and Long-Term Muscle Regeneration (A) Representative EM images demonstrating reduction of condensed heterochromatin in MuSCs of Suv4-20h1SKO mice. Scale bar represents 2 μm. Percentages of MuSC numbers with distinct heterochromatin contents (hetero) in WT and mutant muscles are shown on the right. ∗∗p < 0.01, ∗∗∗p < 0.001 (n = 3). (B and C) Quantifications of H4K20me2 (B) and H3K27me3 (C) Pax7 double-positive cells in Suv4-20h1sKO mutant mice. ∗∗∗p < 0.001 (n = 3). (D) Quantifications of Pax7+/MyoD+ MuSCs. ∗∗∗p < 0.001 (n = 3). (E) Immunofluorescence staining of EdU+/Pax7+ double-positive MuSCs in WT and Suv4-20h1sKO after 14 days of EdU incorporation. Quantifications are shown on the right. ∗p < 0.05 (n = 3). Scale bar represents 20 μm. (F) Macroscopic view of decreased TA muscle mass in Suv4-20h1sKO mutant compared with WT mice after repeated muscle injury. Quantifications of TA muscle masses with and without CTX injection are shown on the right. ∗p < 0.05 (n = 6). (G) Quantifications of MuSC numbers per 1 mm2 in regenerating and non-regenerating TA muscles of Suv4-20h1sKO and WT muscles after three rounds of regeneration. ∗∗p < 0.01 (n = 6). (H) Quantification of Pax7+/MyoG+ cells of WT and Suv4-20h1sKO indicating accelerated differentiation in Suv4-20h1sKO mutant mice. ∗p < 0.05 (n = 3). See also Figure S4. Cell Stem Cell 2016 18, 229-242DOI: (10.1016/j.stem.2015.11.002) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 4 Suv4-20h1-Mediated fHC Formation Is Required for MyoD Gene Silencing in MuSCs (A) RT-qPCR analyses of MyoD upregulation in MuSCs of Suv4-20h1mKO compared with WT mice. ∗p < 0.05 (n = 6). (B) Western blot analysis of increased MyoD protein levels in muscles of Suv4-20h1mKO mice. β-tubulin serves as loading control. (C–F) ChIP-qPCR assays of Suv4-20h1 (C), H4K20me2 (D), histone H3 (E), and H3K4me3 (F) at distinct MyoD regulatory regions of quiescent MuSCs from Suv4-20h1mKO and WT mice. Relative enrichment of Suv4-20h1 and histone H3 was normalized against input DNA, while enrichment of H4K20me2 and H3K4me3 was normalized to histone H3. ∗p < 0.05 compared with IgG control (n = 3). (G) Representative MyoD DNA FISH images of the localization of the MyoD locus (red) in the center of Suv4-20h1mKO MuSC nuclei compared to a peripheral localization in nuclei of WT MuSCs. Quantification of the distance (μm) of MyoD loci relative to the nuclear lamina within different groups of MuSCs (y axis) in WT and Suv4-20h1mKO mice is shown on the right; 150 cells from three different pairs of WT and mutant mice were analyzed by DNA FISH. Scale bar represents 5 μm. See also Figure S5. Cell Stem Cell 2016 18, 229-242DOI: (10.1016/j.stem.2015.11.002) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 5 Reduction of MyoD Expression Partially Rescues Condensed Heterochromatin Formation in Suv4-20h1-Deficient MuSCs (A and B) Representative EM micrographs of heterochromatin condensations in different mouse mutants. Scale bar represents 2 μm. Quantifications of the heterochromatin content are shown below. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (n = 3). (C and D) Immunofluorescence based quantification of H3K27me3+/Pax7+ MuSC in different mouse mutants. See also Figure S6. Cell Stem Cell 2016 18, 229-242DOI: (10.1016/j.stem.2015.11.002) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 6 Reduction of MyoD Expression Partially Restores MuSC Quiescence and Rescues Long-Term Muscle Regeneration in Suv4-20h1-Deficient Muscle (A) Immunofluorescence based quantification of Pax7+/MyoD+ MuSCs in TA muscles of WT and different mutant mice (ten sections per mouse, ∗p < 0.05, ∗∗p < 0.01; n = 5). (B) Macroscopic images of regenerating TA muscles of different mouse mutants after three rounds of regeneration. Quantifications of weights of regenerated muscles are shown on the right. ∗∗p < 0.01 (n = 5). (C) H&E staining of regenerating TA muscles after three rounds of regeneration. Scale bar represents 20 μm. (D) Quantification of MuSC numbers per 100 myonuclei by EM in regenerating muscles from different mouse mutant strains. ∗∗∗p < 0.001 (n = 5). (E) Quantitative assessment of MuSC numbers identified by Pax7 immunofluorescence in regenerating muscles of different mutant strains. ∗p < 0.05, ∗∗p < 0.01 (n = 3). See also Figure S7. Cell Stem Cell 2016 18, 229-242DOI: (10.1016/j.stem.2015.11.002) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 7 MuSCs of mdx Mice Show Reduced Suv4-20h1 Expression and fHC Content (A) Quantification of MyoD+/Pax7+ MuSCs in TA muscles of mdx mice. ∗∗p < 0.01 (n = 3). (B) RT-qPCR analyses of Suv4-20h1 and MyoD expression in FACS-isolated Pax7+ MuSC from WT and mdx mice. ∗p < 0.05, ∗∗∗p < 0.001 (n = 3). (C and D) Quantifications of H4K20me2+/Pax7+ (C) and H3K27me3+/Pax7+ (D) MuSCs in TA muscles. H4K20me2-positive MuSCs were separated into three groups according to staining intensity. ∗p < 0.05, ∗∗p < 0.01, (n = 3). (E) Representative EM images demonstrating reduction of condensed heterochromatin in MuSCs of mdx compared to WT mice. Scale bar represents 2 μm. Quantitative assessment of the heterochromatin content in MuSCs of WT and mdx mice are shown on the right. ∗∗p < 0.01, ∗∗∗∗p < 0.0001 (n = 3). (F) Simplified model of the role of Suv4-20h1 in the regulation of fHC formation and MuSC quiescence. Suv4-20h1-dependent fHC formation arrests the MyoD gene locus in the nuclear periphery where transcriptional activity is low. See also Figure S6. Cell Stem Cell 2016 18, 229-242DOI: (10.1016/j.stem.2015.11.002) Copyright © 2016 Elsevier Inc. Terms and Conditions